Ratha-Korn Vilaichone
Overview
Explore the profile of Ratha-Korn Vilaichone including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
111
Citations
1306
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Aumpan N, Gamnarai P, Wongcha-Um A, Miftahussurur M, Yamaoka Y, Vilaichone R
Heliyon
. 2024 Nov;
10(21):e39189.
PMID: 39512463
Background: eradication is effective for gastric cancer prevention. Treatment failure is caused by increased antibiotic resistance. This study aimed to determine eradication rates and perform cost analysis between susceptibility-guided therapy...
2.
Tourrette E, Torres R, Svensson S, Matsumoto T, Miftahussurur M, Fauzia K, et al.
Nature
. 2024 Oct;
635(8037):178-185.
PMID: 39415013
Helicobacter pylori disturbs the stomach lining during long-term colonization of its human host, with sequelae including ulcers and gastric cancer. Numerous H. pylori virulence factors have been identified, showing extensive...
3.
Sugihartono T, Hidayat A, Alfaray R, Lusida M, Mahmudah I, Aftab H, et al.
J Clin Med
. 2024 Oct;
13(19).
PMID: 39407891
The diverse clinical characteristics of erosive esophagitis (EE) and symptom perception in patients with gastroesophageal reflux disease (GERD) remain a major challenge in understanding their underlying pathogenesis. This study aimed...
4.
Tungtrongchitr N, Bongkotvirawan P, Ratana-Amornpin S, Siramolpiwat S, Eiamsitrakoon T, Gamnarai P, et al.
Sci Rep
. 2024 Apr;
14(1):8986.
PMID: 38637591
Potassium-competitive acid blockers (P-CABs) provide potent acid inhibition, yet studies on P-CAB-based quadruple therapy for H. pylori eradication are limited. We theorized that integrating bismuth subsalicylate into a quadruple therapy...
5.
Hidayat A, Waskito L, Sugihartono T, Aftab H, Rezkitha Y, Vilaichone R, et al.
Intest Res
. 2024 Mar;
22(3):286-296.
PMID: 38528371
Irritable bowel syndrome (IBS) is a highly prevalent gastrointestinal disorder associated with substantial impairment which considerably burdens healthcare systems worldwide. Research on IBS has largely been conducted in high-income countries...
6.
Bongkotvirawan P, Aumpan N, Pornthisarn B, Chonprasertsuk S, Siramolpiwat S, Bhanthumkomol P, et al.
Womens Health Rep (New Rochelle)
. 2024 Mar;
5(1):178-185.
PMID: 38440419
Introduction: Association of Southeast Asian Nations (ASEAN) countries have high infections, and gastric cancer (GC) is a leading fatal cancer in this region, especially in female patients. This study aimed...
7.
Chatrangsun B, Aumpan N, Pornthisarn B, Chonprasertsuk S, Siramolpiwat S, Bhanthumkomol P, et al.
BMC Gastroenterol
. 2024 Jan;
24(1):46.
PMID: 38273222
Background: Helicobacter pylori (H. pylori) is associated with gastric cancer. Early and accurate diagnosis of H. pylori infection can reduce risk of gastric cancer. Conventional white light imaging (WLI) and...
8.
Aumpan N, Issariyakulkarn N, Mahachai V, Graham D, Yamaoka Y, Vilaichone R
PLoS One
. 2023 Nov;
18(11):e0294403.
PMID: 38033026
Background: Helicobacter pylori treatment failure remains a challenging problem. This study aimed to identify predictive factors for successful eradication in patients following treatment failures. Methods: This was a retrospective cohort...
9.
Kingkaew E, Woraprayote W, Booncharoen A, Niwasabutra K, Janyaphisan T, Vilaichone R, et al.
Sci Rep
. 2023 Nov;
13(1):20362.
PMID: 37990119
Helicobacter pylori, linked to gastric diseases, is targeted for probiotic treatment through bacteriocin production. Bacteriocins have gained recognition for their non-toxic effects on host cells and their ability to combat...
10.
Kiattiweerasak A, Bongkotvirawan P, Aumpan N, Yamaoka Y, Miftahussurur M, Vilaichone R
PLoS One
. 2023 Sep;
18(9):e0291926.
PMID: 37729185
Background: Gastric cancer remains the fourth leading cause of cancer-related death worldwide. Significant number of gastric cancer patients presented with bleeding. Objective: This study aimed to identify risk factors and...